It is written: PharmaCyte Biotech is meeting with the U.S. FDA today to discuss our upcoming clinical trial in #PancreaticCancer - This meeting with the FDA's Center for Biologics Evaluation and Research (CBER) marks the culmination of years of hard work by the entire team of oncologists, clinicians, doctors and researchers that surrounds our pancreatic cancer therapy.
A special thanks to our partners at Austrianova for this amazing technology and pancreatic cancer therapy and for your dedication and hard work, and to our many dedicated shareholders who have helped to make this day possible - your patience is sincerely appreciated! We look forward to sharing the news from today's meeting with the public very soon.
News 
Market Data 
Discover 
